Information on what the Immunisation Advisory Committee (IAC) will be considering at its upcoming meeting in September 2026. Matters arisingRSV Programme overviewThe Committee will discuss the potential approach to an RSV immunisation programme in New Zealand. All RSV related applications(external link)Recombinant zoster vaccine (Shingrix) for immunocompromised people at increased risk of shinglesThe Committee will discuss widening access to the recombinant zoster vaccine for immunocompromised people who are at increased risk of shingles and its complications. The Committee previously considered this topic at their March 2024 Immunisation Advisory Committee meeting(external link) and their June 2025 Immunisation Advisory Committee(external link). Application for Human Papillomavirus 9-valent vaccine for people with HIV(external link)